NYU Langone's Perlmutter Cancer Center Earns Redesignation as a Comprehensive Cancer Center from the National Cancer Institute
NEW YORK, April 18, 2024 /PRNewswire/ -- NYU Langone Health's Laura and Isaac Perlmutter Cancer Center has once again been designated as a Comprehensive Cancer Center, the highest ranking awarded by the National Cancer Institute and further validation that it provides state-of-the-art, research-based approaches to preventing, detecting, and treating cancer.
- NEW YORK, April 18, 2024 /PRNewswire/ -- NYU Langone Health's Laura and Isaac Perlmutter Cancer Center has once again been designated as a Comprehensive Cancer Center, the highest ranking awarded by the National Cancer Institute and further validation that it provides state-of-the-art, research-based approaches to preventing, detecting, and treating cancer.
- Perlmutter Cancer Center is among only 56 institutions recognized across the nation for earning this elite distinction.
- Perlmutter Cancer Center achieved its ranking by demonstrating success in the following areas:
Developing and offering the most advanced therapies and innovative clinical trials. - Experts at Perlmutter Cancer Center have also implemented screening approaches to diagnose lung cancer in non-smokers.